What caused a 14-year-old girl to develop chronic, intractable light-sensitive skin eruptions on her face, upper body, and extremities? That's what Ruth Ann Vleugels, MD, MPH, of Harvard Medical ...
An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis, a randomized phase II study showed.
Belonging to the same group of autoimmune diseases, both dermatomyositis and polymyositis cause muscle inflammation and weakness. But dermatomyositis also affects your skin and is more likely to ...
NEW ORLEANS — A monoclonal antibody targeting interferon beta (IFN-beta) provided substantial reductions in the skin lesions associated with dermatomyositis in a double-blind, placebo-controlled phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback